tel.: +7 (3952) 43-67-57
Irkutsk city, 2-nd Zheleznodorozhnaya st., 9
hivirk@mail.ru
Ðóññêèé / English
s
Ñòóïåíè Âàøå ó÷àñòèå Ñîöèàëüíîå áþðî Øêîëà ïàöèåíòà
Phone
«Hot line on HIV issues »
43-67-57
Phone
«Hot line on rehabilitation issues »
43-67-57
F. A. Q.
Question:

Superbly illuminating data here, thnkas!

Leaflet “Combivir. The power of two in the simplicity of one”

<< Back to contents

Date received: 2008-06-09

Language: Ðóññêèé

Code: 304

Year published: 2006

Organization: GlaxoSmithKline Export Ltd.

Carrier: Printed

The development of ARV drugs has been conducted in several directions. One of the directions for the GlaxoSmithKline Company - development of combined drugs that are more convenient in use and at the same time providing high antiretroviral activity. In 1997 in the USA the first combined drug to treat HIV-infection was approved - Combivir, containing two nucleoside reverse transcriptase inhibitors - lamivudine and zidovudine. This leaflet informs about these inhibitors.

The goal of these guidelines is to provide organizations with information to assist in protection of interests of target groups. The information...

December 1 - World AIDS Day

Website is supported by
American Red Cross

Developed by Prime Group LTD.